316 related articles for article (PubMed ID: 18846035)
1. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
[TBL] [Abstract][Full Text] [Related]
3. Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure.
Qvigstad E; Brattelid T; Sjaastad I; Andressen KW; Krobert KA; Birkeland JA; Sejersted OM; Kaumann AJ; Skomedal T; Osnes JB; Levy FO
Cardiovasc Res; 2005 Mar; 65(4):869-78. PubMed ID: 15721867
[TBL] [Abstract][Full Text] [Related]
4. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
[TBL] [Abstract][Full Text] [Related]
5. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and β-adrenoceptors in failing human heart.
Riise J; Ørstavik Ø; Qvigstad E; Dahl CP; Osnes JB; Skomedal T; Levy FO; Krobert KA
Basic Res Cardiol; 2012 Sep; 107(5):295. PubMed ID: 22923058
[TBL] [Abstract][Full Text] [Related]
8. The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Hussain RI; Aronsen JM; Afzal F; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
J Mol Cell Cardiol; 2013 Mar; 56():129-38. PubMed ID: 23220156
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
11. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
[TBL] [Abstract][Full Text] [Related]
12. Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation.
Dolce B; Christ T; Grammatika Pavlidou N; Yildirim Y; Reichenspurner H; Eschenhagen T; Nikolaev VO; Kaumann AJ; Molina CE
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):291-298. PubMed ID: 32949251
[TBL] [Abstract][Full Text] [Related]
13. Ontogenic changes of the control by phosphodiesterase-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT(4) receptors.
Galindo-Tovar A; Vargas ML; Escudero E; Kaumann AJ
Br J Pharmacol; 2009 Jan; 156(2):237-49. PubMed ID: 19154438
[TBL] [Abstract][Full Text] [Related]
14. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle.
Brattelid T; Qvigstad E; Birkeland JA; Swift F; Bekkevold SV; Krobert KA; Sejersted OM; Skomedal T; Osnes JB; Levy FO; Sjaastad I
J Mol Cell Cardiol; 2007 Dec; 43(6):767-79. PubMed ID: 17936780
[TBL] [Abstract][Full Text] [Related]
15. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
[TBL] [Abstract][Full Text] [Related]
17. Which phosphodiesterase can decrease cardiac effects of 5-HT
Neumann J; Käufler B; Gergs U
Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):991-1004. PubMed ID: 31016326
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
Vargas ML; Hernandez J; Kaumann AJ
Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
[TBL] [Abstract][Full Text] [Related]
19. The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium.
Ørstavik Ø; Manfra O; Andressen KW; Andersen GØ; Skomedal T; Osnes JB; Levy FO; Krobert KA
PLoS One; 2015; 10(3):e0115547. PubMed ID: 25738589
[TBL] [Abstract][Full Text] [Related]
20. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
